McGill University, Montreal
Low doses of corticosteroids may be associated with reduced risk of acute MI
Published in Healthcare Finance, Tax and Law Weekly, June 1st, 2005
According to published research from Canada, "Inflammation plays a major role in the development and complications of atherosclerosis. [In our study], the dose-related impact of inhaled corticosteroids (ICS), used for their anti-inflammatory properties, on the risk of acute myocardial infarction (AMI) is studied in a cohort of chronic obstructive pulmonary disease (COPD) patients."
L. Huiart and colleagues of McGill University explained, "Saskatchewan (Canada) health services databases were used to form a population-based cohort of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AMS Health Sciences, Inc.
Nutritional supplements company reports loss of $0.19 per share - Abaxis, Inc.8
Blood analysis system maker reports 8% increase in revenue - Able Laboratories, Inc.
Generic pharmaceuticals maker reports 43.1% increase in sales - Aceto Corporation
Sales increase 4% for biotech company - Actimis Pharmaceuticals, Inc.
Pharmaceutical company completes $6M series A financing - Acura Pharmaceuticals, Inc.
Pharmaceutical firm reports quarterly loss of $1.9M - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
